SCHEMBL500719

SCHEMBL500719

O=C(O)c1cn(C2CC2)c2c(F)c(F)c(F)cc2c1=O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 7/20 0.71
TOP2B Q02880 7/20 0.71
ALDH1A1 P00352 5/20 0.57
POLB P06746 2/20 0.57
OPRM1 P35372 2/20 0.57
CHRM2 P08172 1/20 0.57
CHRM1 P11229 1/20 0.57
OPRD1 P41143 1/20 0.57
KCNH2 Q12809 5/20 0.54
KDM4E B2RXH2 4/20 0.54
HPGD P15428 3/20 0.54
HSD17B10 Q99714 3/20 0.54
LMNA P02545 2/20 0.54
CYP1A2 P05177 1/20 0.54
CYP2C9 P11712 1/20 0.54
PRKD3 O94806 1/20 0.53
ALOX15 P16050 1/20 0.53
CLK2 P49760 1/20 0.53
CLK4 Q9HAZ1 1/20 0.53
TDP1 Q9NUW8 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29463823 1.00 TOP2A (0.71) TOP2ATOP2BALDH1A1POLBOPRM1
Potassium SCHEMBL10510827 0.99 TOP2A (0.69) TOP2ATOP2BALDH1A1POLBOPRM1
SCHEMBL10511115 0.99 TOP2A (0.69) TOP2ATOP2BALDH1A1POLBOPRM1
SCHEMBL10510815 0.99 TOP2A (0.69) TOP2ATOP2BALDH1A1POLBOPRM1
SCHEMBL10511131 0.99 TOP2A (0.69) TOP2ATOP2BALDH1A1POLBOPRM1
SCHEMBL10680678 0.95 TOP2A (0.65) TOP2ATOP2BALDH1A1POLBOPRM1
SCHEMBL10677963 0.95 TOP2A (0.65) TOP2ATOP2BALDH1A1POLBOPRM1
SCHEMBL10679531 0.94 TOP2A (0.64) TOP2ATOP2BALDH1A1POLBOPRM1
SCHEMBL584841 0.90 TOP2A (0.68) TOP2ATOP2BALDH1A1POLBOPRM1
SCHEMBL30320686 0.90 TOP2A (0.68) TOP2ATOP2BALDH1A1POLBOPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 334 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111989314-B Method for hydrolyzing quinolone formate 拜耳动物保健有限责任公司 2024-04-30 CN claimed
EP-3784656-B1 PROCESS FOR THE HYDROLYSIS OF QUINOLONE CARBOXYLIC ESTERS ELANCO ANIMAL HEALTH GMBH (DE) 2023-06-28 EP claimed
US-11332444-B2 Method for the hydrolysis of quinolonecarboxylic esters BAYER ANIMAL HEALTH GMBH (DE) 2022-05-17 US claimed
CN-112641773-A Composition containing heterocyclic compound and use thereof 黄泳华 2021-04-13 CN claimed
CN-111514125-B Composition containing quinolone compound and edetic acid compound 中山万汉制药有限公司 2021-03-23 CN claimed
US-20210078950-A1 METHOD FOR THE HYDROLYSIS OF QUINOLONECARBOXYLIC ESTERS ELANCO ANIMAL HEALTH GMBH (DE) 2021-03-18 US claimed
EP-3784656-A1 PROCESS FOR THE HYDROLYSIS OF QUINOLONE CARBOXYLIC ESTERS Bayer Animal Health GmbH (DE) 2021-03-03 EP claimed
CN-111989314-A Process for hydrolysis of quinolone formates 拜耳动物保健有限责任公司 2020-11-24 CN claimed
CN-111514125-A Composition containing quinolone compound and edetic acid compound 中山万汉制药有限公司 2020-08-11 CN claimed
CN-111150734-A Compositions containing mixtures of quinolinone derivatives and uses thereof 黄泳华 2020-05-15 CN claimed
EP-1236718-B1 Improved process for the preparation of fluoro-quinolonecarboxylic acids BAYER CHEMICALS AG (DE) 2004-08-11 EP claimed
US-6590101-B2 Hydrolysis of the corresponding C1-C4-alkyl esters with addition of water, acetic acid, and sulfuric acid using a drastically reduced amount of sulfuric acid BAYER AKTIENGESELLSCHAFT (DE) 2003-07-08 US claimed
EP-1236718-A1 Improved process for the preparation of fluoro-quinolonecarboxylic acids BAYER AG (DE) 2002-09-04 EP claimed
US-20020120138-A1 Process for the preparation of fluoroquinolonecarboxylic acids LANXESS DEUTSCHLAND GMBH (DE) 2002-08-29 US claimed
EP-0198678-B1 A PROCESS FOR PREPARING SUBSTITUTED QUINOLINE-3-CARBOXYLIC ACIDS WARNER-LAMBERT COMPANY (US) 1991-08-21 EP claimed
EP-0200307-B1 IMPROVED PROCESS FOR PRODUCTION OF QUINOLINE-3-CARBOXYLIC ACID ANTIBACTERIAL AGENTS WARNER-LAMBERT COMPANY (US) 1989-12-20 EP claimed
EP-0126355-B1 7-AMINO-1-CYCLOPROPYL-6,8-DIFLUORO-1,4-DIHYDRO-4-OXO-3-QUINOLINE-CARBOXYLIC ACID, PROCESSES FOR THEIR PREPARATION AND ANTIBACTERIAL AGENTS CONTAINING THEM BAYER AG (DE) 1987-09-09 EP claimed
EP-0198678-A2 A process for preparing substituted quinoline-3-carboxylic acids WARNER-LAMBERT COMPANY (US) 1986-10-22 EP claimed
US-4578473-A Process for quinoline-3-carboxylic acid antibacterial agents WARNER-LAMBERT COMPANY (US) 1986-03-25 US claimed
EP-0126355-A1 7-Amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-3-quinoline-carboxylic acid, processes for their preparation and antibacterial agents containing them BAYER AG (DE) 1984-11-28 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020120138-A1 Process for the preparation of fluoroquinolonecarboxylic acids ADH1C, CTRC, ADH1A TOP2A 352/4885TOP2B 365/4885ALDH1A1 124/4885
US-20210078950-A1 METHOD FOR THE HYDROLYSIS OF QUINOLONECARBOXYLIC ESTERS NQO2, PGD, ALAD TOP2A 38/4885TOP2B 35/4885ALDH1A1 274/4885
US-11332444-B2 Method for the hydrolysis of quinolonecarboxylic esters NQO2, PGD, ALAD TOP2A 38/4885TOP2B 35/4885ALDH1A1 274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.